The store will not work correctly when cookies are disabled.
9-benzyl-6-(benzylthio)-9H-purine
ID: ALA4755966
Cas Number: 21186-46-9
PubChem CID: 231021
Max Phase: Preclinical
Molecular Formula: C19H16N4S
Molecular Weight: 332.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: c1ccc(CSc2ncnc3c2ncn3Cc2ccccc2)cc1
Standard InChI: InChI=1S/C19H16N4S/c1-3-7-15(8-4-1)11-23-14-22-17-18(23)20-13-21-19(17)24-12-16-9-5-2-6-10-16/h1-10,13-14H,11-12H2
Standard InChI Key: HYFZJHDNXSLUJU-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
9.7471 -10.9701 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7460 -11.7897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4540 -12.1986 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4522 -10.5613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1608 -10.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1656 -11.7851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9457 -12.0336 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4230 -11.3685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9379 -10.7091 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4498 -9.7441 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.7408 -9.3376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0344 -9.7483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3292 -9.3410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6232 -9.7510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6252 -10.5691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3391 -10.9754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0422 -10.5630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2027 -12.8093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0030 -12.9746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2548 -13.7503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0543 -13.9158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5985 -13.3049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3376 -12.5260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5387 -12.3643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
7 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 332.43 | Molecular Weight (Monoisotopic): 332.1096 | AlogP: 4.17 | #Rotatable Bonds: 5 |
Polar Surface Area: 43.60 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.00 | CX LogP: 4.49 | CX LogD: 4.49 |
Aromatic Rings: 4 | Heavy Atoms: 24 | QED Weighted: 0.41 | Np Likeness Score: -1.40 |
References
1. Rojas-Prats E,Martinez-Gonzalez L,Gonzalo-Consuegra C,Liachko NF,Perez C,Ramírez D,Kraemer BC,Martin-Requero Á,Perez DI,Gil C,de Lago E,Martinez A. (2021) Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis., 210 [PMID:33139113] [10.1016/j.ejmech.2020.112968] |